Neo Medical receives FDA clearance of pedicle screw system for late-stage tumor indication
Click Here to Manage Email Alerts
Neo Medical has announced an additional FDA 510(k) clearance of its pedicle screw system for advanced-stage tumor indications in combination with BonOs Inject cement from Osartis, according to a press release.
The newest FDA clearance for this pedicle screw system will allow surgeons to augment universal screw designs with cement for patients with late-stage tumors and poor bone quality, according to the release.
“The FDA 510(k) clearance and CE certification announced today come as we continue to expand our portfolio and develop new applications for Neo pedicle screw system,” Vincent Lefauconnier, CEO of Neo Medical, said in the release. “The rest of the year should see the company continuing to expand its activities, including in the digital space with the roll-out of groundbreaking augmented reality solutions to complement our existing platform of physical products,” he added.
Read more about
Click Here to Manage Email Alerts